Pfizer Pays Almost $120 Million For App That Detects COVID From a Cough
Pharma giant Pfizer has shelled out nearly $120 million to acquire a small Australian company claiming to have developed a smartphone app that can accurately diagnose COVID-19 by analyzing the sound of a cough. For around a decade small Australian digital healthcare company ResApp has been working on developing an Read more…






